| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Achieving access to haemophilia care in low-income and lower-middle-income countries: expanded Humanitarian Aid Program of the World Federation of Hemophilia after 5 years
|
Pierce, Glenn F
|
|
|
9 |
9 |
p. e689-e697
|
artikel
|
| 2 |
A roadmap during parenting
|
Lucas, Tiffany L
|
|
|
9 |
9 |
p. e644
|
artikel
|
| 3 |
Control participants of randomised trials: an often forgotten, vulnerable population
|
Mohyuddin, Ghulam Rehman
|
|
|
9 |
9 |
p. e634-e636
|
artikel
|
| 4 |
Correction to Lancet Haematol 2022; 9: e563–72
|
|
|
|
9 |
9 |
p. e641
|
artikel
|
| 5 |
Correction to Lancet Haematol 2022; Published online July 27. https://doi.org/10.1016/S2352-3026(22)00206-X
|
|
|
|
9 |
9 |
p. e641
|
artikel
|
| 6 |
Development of an international standard set of outcome measures for patients with venous thromboembolism: an International Consortium for Health Outcomes Measurement consensus recommendation
|
Gwozdz, Adam M
|
|
|
9 |
9 |
p. e698-e706
|
artikel
|
| 7 |
Factors to consider when assessing the IDOCS study
|
Uchiyama, Keita
|
|
|
9 |
9 |
p. e638
|
artikel
|
| 8 |
Factors to consider when assessing the IDOCS study
|
Clarke, Lisa
|
|
|
9 |
9 |
p. e637-e638
|
artikel
|
| 9 |
Factors to consider when assessing the IDOCS study
|
Vinke, Joanna Sophia J
|
|
|
9 |
9 |
p. e638-e639
|
artikel
|
| 10 |
Factors to consider when assessing the IDOCS study – Authors’ reply
|
Miles, Lachlan F
|
|
|
9 |
9 |
p. e639-e640
|
artikel
|
| 11 |
Global effort to evacuate Ukrainian children with cancer and blood disorders who have been affected by war
|
Agulnik, Asya
|
|
|
9 |
9 |
p. e645-e647
|
artikel
|
| 12 |
Haploidentical bone marrow transplantation for severe aplastic anaemia: looking to the future
|
Frieri, Camilla
|
|
|
9 |
9 |
p. e629-e630
|
artikel
|
| 13 |
Haploidentical bone marrow transplantation in patients with relapsed or refractory severe aplastic anaemia in the USA (BMT CTN 1502): a multicentre, single-arm, phase 2 trial
|
DeZern, Amy E
|
|
|
9 |
9 |
p. e660-e669
|
artikel
|
| 14 |
Improving the global reporting of multiple myeloma: a focus on low-income and middle-income countries
|
Swaminathan, Rajaraman
|
|
|
9 |
9 |
p. e631-e632
|
artikel
|
| 15 |
International Society on Thrombosis and Haemostasis Congress 2022
|
Smith, Lan-Lan
|
|
|
9 |
9 |
p. e642-e643
|
artikel
|
| 16 |
Pegcetacoplan: climbing up the complement cascade
|
Gaya, Anna
|
|
|
9 |
9 |
p. e628-e629
|
artikel
|
| 17 |
Pegcetacoplan versus eculizumab in patients with paroxysmal nocturnal haemoglobinuria (PEGASUS): 48-week follow-up of a randomised, open-label, phase 3, active-comparator, controlled trial
|
de Latour, Régis Peffault
|
|
|
9 |
9 |
p. e648-e659
|
artikel
|
| 18 |
Rates of laboratory adverse events by course in paediatric leukaemia ascertained with automated electronic health record extraction: a retrospective cohort study from the Children's Oncology Group
|
Miller, Tamara P
|
|
|
9 |
9 |
p. e678-e688
|
artikel
|
| 19 |
Reducing toxic waste: improving toxicity capture in childhood cancer
|
Gupta, Sumit
|
|
|
9 |
9 |
p. e632-e634
|
artikel
|
| 20 |
Risk factors for neonatal thrombosis
|
Bhat, Rukhmi
|
|
|
9 |
9 |
p. e637
|
artikel
|
| 21 |
The epidemiological landscape of multiple myeloma: a global cancer registry estimate of disease burden, risk factors, and temporal trends
|
Huang, Junjie
|
|
|
9 |
9 |
p. e670-e677
|
artikel
|
| 22 |
UK Infected Blood Inquiry: long-awaited progress?
|
The Lancet Haematology,
|
|
|
9 |
9 |
p. e627
|
artikel
|
Tijdschrift beschrijving